National plans and awareness campaigns as priorities for achieving global brain health.

Neurological conditions are the leading cause of death and disability combined. This public health crisis has become a global priority with the introduction of WHO's Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders 2022-2031 (IGAP). 18 months after this plan was adopted, global neurology stakeholders, including representatives of the OneNeurology Partnership (a consortium uniting global neurology organisations), take stock and advocate for urgent acceleration of IGAP implementation.

Which terms should be used to describe medications used in the treatment of seizure disorders? An ILAE position paper.

A variety of terms, such as "antiepileptic," "anticonvulsant," and "antiseizure" have been historically applied to medications for the treatment of seizure disorders. Terminology is important because using terms that do not accurately reflect the action of specific treatments may result in a misunderstanding of their effects and inappropriate use. The present International League Against Epilepsy (ILAE) position paper used a Delphi approach to develop recommendations on English-language terminology applicable to pharmacological agents currently approved for treating seizure disorders.

Report from a Workshop on Accelerating the Development of Treatments for Inherited Retinal Dystrophies Associated with Mutations in the Gene.

Unlabelled: The Foundation Fighting Blindness, family organizations, and the Fund for Sight convened a jointly organized workshop in Columbia, Maryland, on November 19, 2019. The purpose of the workshop was to share perspectives on what is known about the -associated retinal dystrophies (RDs) and discuss the advancement of therapies, primarily gene therapy, for people with mutations in the gene which cause Leber congenital amaurosis 13 (LCA13). The workshop began with presentations on the landscape, patient perspectives, the use of statistical modeling for clinical trial design, and the Foundation's My Retina Tracker Registry.